Welcome to Aetos Life Care. Looking for a reliable pharmaceutical manufacturer?

Doxazosin Tablets 4 mg

Doxazosin is an alpha-1 adrenergic receptor blocker used in the treatment of hypertension (high blood pressure) and benign prostatic hyperplasia (BPH). By relaxing blood vessels and smooth muscle in the bladder neck and prostate, Doxazosin helps lower blood pressure and improve urinary flow in men with prostate enlargement. The 4 mg dosage provides effective once-daily management with a low risk of orthostatic hypotension when titrated properly.

Enquiry Now

Description

Indications:

  • Essential hypertension (as monotherapy or in combination)
  • Benign prostatic hyperplasia (BPH)
  • Ureteral stone passage (off-label use in some countries)

Key Features:

  • Long-acting formulation for once-daily dosing
  • Dual benefit for hypertension and BPH
  • Excellent tolerability profile
  • Blister-packed in ALU-PVC for product integrity
  • Manufactured under WHO-GMP and EU-GMP standards

Global Manufacturing & Export:

Aetos Life Care exports Doxazosin Tablets 4 mg to multiple regulated and semi-regulated markets across Latin America, Africa, Asia, CIS, and Eastern Europe. All products are manufactured in state-of-the-art facilities with stringent quality controls, ensuring compliance with international pharmacopoeial and regulatory standards.

Third-Party Contract Manufacturing:

We offer customized third-party contract manufacturing for Doxazosin Tablets. Services include formulation development, product registration assistance, custom packaging and private labeling for distributors, marketing authorization holders, and government procurement bodies worldwide.

Storage Conditions:

Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children.

Leading Manufacturer and Exporter of Pharmaceuticals Across Continents

Aetos Life Care is a trusted manufacturer and exporter of high-quality generic and specialty medicines, serving over 40 countries across Latin America, Africa, Asia, Europe, and the CIS region. We have a strong presence in key markets, including Iraq, Jordan, Saudi Arabia, UAE, Ukraine, Kazakhstan, Venezuela, Ecuador, and more. Backed by 15 WHO-GMP accredited facilities designed to meet EU-GMP standards, we ensure the highest quality, safety, and compliance in every product we deliver.

Iraq, Jordan, Riyadh (Saudi Arabia), Dubai (UAE)

Ukraine, Kazakhstan, Turkmenistan, Tajikistan

Venezuela, Ecuador, Peru, Paraguay, Panama, Costa Rica, El Salvador

Cameroon, South Sudan, Angola

Myanmar